138 related articles for article (PubMed ID: 20047982)
1. Long-term improvement of lipid profile in patients with refractory systemic lupus erythematosus treated with B-cell depletion therapy: a retrospective observational study.
Pego-Reigosa JM; Lu TY; Fontanillo MF; del Campo-Pérez V; Rahman A; Isenberg DA
Rheumatology (Oxford); 2010 Apr; 49(4):691-6. PubMed ID: 20047982
[TBL] [Abstract][Full Text] [Related]
2. B cell depletion therapy in systemic lupus erythematosus: long-term follow-up and predictors of response.
Ng KP; Cambridge G; Leandro MJ; Edwards JC; Ehrenstein M; Isenberg DA
Ann Rheum Dis; 2007 Sep; 66(9):1259-62. PubMed ID: 17412738
[TBL] [Abstract][Full Text] [Related]
3. A retrospective seven-year analysis of the use of B cell depletion therapy in systemic lupus erythematosus at University College London Hospital: the first fifty patients.
Lu TY; Ng KP; Cambridge G; Leandro MJ; Edwards JC; Ehrenstein M; Isenberg DA
Arthritis Rheum; 2009 Apr; 61(4):482-7. PubMed ID: 19333973
[TBL] [Abstract][Full Text] [Related]
4. B cell depletion therapy in systemic lupus erythematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response.
Cambridge G; Isenberg DA; Edwards JC; Leandro MJ; Migone TS; Teodorescu M; Stohl W
Ann Rheum Dis; 2008 Jul; 67(7):1011-6. PubMed ID: 17962238
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic changes of lymphocytes in patients with systemic lupus erythematosus who are in longterm remission after B cell depletion therapy with rituximab.
Iwata S; Saito K; Tokunaga M; Yamaoka K; Nawata M; Yukawa S; Hanami K; Fukuyo S; Miyagawa I; Kubo S; Tanaka Y
J Rheumatol; 2011 Apr; 38(4):633-41. PubMed ID: 21159836
[TBL] [Abstract][Full Text] [Related]
6. Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: Remission, relapse, and re-treatment.
Smith KG; Jones RB; Burns SM; Jayne DR
Arthritis Rheum; 2006 Sep; 54(9):2970-82. PubMed ID: 16947528
[TBL] [Abstract][Full Text] [Related]
7. B-cell depletion for autoimmune thrombocytopenia and autoimmune hemolytic anemia in pediatric systemic lupus erythematosus.
Kumar S; Benseler SM; Kirby-Allen M; Silverman ED
Pediatrics; 2009 Jan; 123(1):e159-63. PubMed ID: 19074962
[TBL] [Abstract][Full Text] [Related]
8. Multicenter longitudinal study of B-lymphocyte depletion in refractory systemic lupus erythematosus: the LESIMAB study.
Fernández-Nebro A; de la Fuente JL; Carreño L; Izquierdo MG; Tomero E; Rúa-Figueroa I; Hernández-Cruz BE; Narváez J; Ucar E; Olivé A; Zea A; Fernández-Castro M; Raya-Álvarez E; Pego-Reigosa JM; Freire M; Martínez-Taboada VM; Pérez-Venegas J; Sánchez-Atrio AI; Villa-Blanco I; Manrique-Arija S; López-Longo FJ; Carreira PE; Martínez-Pérez R; García-Vicuña R
Lupus; 2012 Sep; 21(10):1063-76. PubMed ID: 22786985
[TBL] [Abstract][Full Text] [Related]
9. Elevated serum BAFF levels are associated with rising anti-double-stranded DNA antibody levels and disease flare following B cell depletion therapy in systemic lupus erythematosus.
Carter LM; Isenberg DA; Ehrenstein MR
Arthritis Rheum; 2013 Oct; 65(10):2672-9. PubMed ID: 23839909
[TBL] [Abstract][Full Text] [Related]
10. Takayasu arteritis is characterised by disturbances of B cell homeostasis and responds to B cell depletion therapy with rituximab.
Hoyer BF; Mumtaz IM; Loddenkemper K; Bruns A; Sengler C; Hermann KG; Maza S; Keitzer R; Burmester GR; Buttgereit F; Radbruch A; Hiepe F
Ann Rheum Dis; 2012 Jan; 71(1):75-9. PubMed ID: 21953334
[TBL] [Abstract][Full Text] [Related]
11. Long-term efficacy and safety of rituximab in refractory and relapsing systemic lupus erythematosus.
Catapano F; Chaudhry AN; Jones RB; Smith KG; Jayne DW
Nephrol Dial Transplant; 2010 Nov; 25(11):3586-92. PubMed ID: 20466686
[TBL] [Abstract][Full Text] [Related]
12. The effects of rituximab on the lipid profile of patients with active systemic lupus erythematosus: results from a nationwide cohort in Spain (LESIMAB).
Fernández-Nebro A; Marenco JL; López-Longo F; Galindo M; Hernández-Cruz BE; Narváez J; Rúa-Figueroa I; Raya-Alvarez E; Zea A; Freire M; Sánchez-Atrio AI; García-Vicuña R; Pego-Reigosa JM; Manrique-Arija S; Nieves-Martín L; Carreño L;
Lupus; 2014 Sep; 23(10):1014-22. PubMed ID: 24833667
[TBL] [Abstract][Full Text] [Related]
13. Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus.
Albert D; Dunham J; Khan S; Stansberry J; Kolasinski S; Tsai D; Pullman-Mooar S; Barnack F; Striebich C; Looney RJ; Prak ET; Kimberly R; Zhang Y; Eisenberg R
Ann Rheum Dis; 2008 Dec; 67(12):1724-31. PubMed ID: 18250115
[TBL] [Abstract][Full Text] [Related]
14. B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients.
Leandro MJ; Cambridge G; Edwards JC; Ehrenstein MR; Isenberg DA
Rheumatology (Oxford); 2005 Dec; 44(12):1542-5. PubMed ID: 16188950
[TBL] [Abstract][Full Text] [Related]
15. Rituximab - shadow, illusion or light?
van Vollenhoven RF
Autoimmun Rev; 2012 Jun; 11(8):563-7. PubMed ID: 22036829
[TBL] [Abstract][Full Text] [Related]
16. B cell depletion therapy for patients with systemic lupus erythematosus results in a significant drop in anticardiolipin antibody titres.
Ioannou Y; Lambrianides A; Cambridge G; Leandro MJ; Edwards JC; Isenberg DA
Ann Rheum Dis; 2008 Mar; 67(3):425-6. PubMed ID: 17905784
[TBL] [Abstract][Full Text] [Related]
17. B cell depletion therapy in systemic lupus erythematosus: effect on autoantibody and antimicrobial antibody profiles.
Cambridge G; Leandro MJ; Teodorescu M; Manson J; Rahman A; Isenberg DA; Edwards JC
Arthritis Rheum; 2006 Nov; 54(11):3612-22. PubMed ID: 17075806
[TBL] [Abstract][Full Text] [Related]
18. Delayed memory B cell recovery in peripheral blood and lymphoid tissue in systemic lupus erythematosus after B cell depletion therapy.
Anolik JH; Barnard J; Owen T; Zheng B; Kemshetti S; Looney RJ; Sanz I
Arthritis Rheum; 2007 Sep; 56(9):3044-56. PubMed ID: 17763423
[TBL] [Abstract][Full Text] [Related]
19. B-cell depletion therapy and pregnancy outcome in severe, refractory systemic autoimmune diseases.
Sangle SR; Lutalo PM; Davies RJ; Khamashta MA; D'Cruz DP
J Autoimmun; 2013 Jun; 43():55-9. PubMed ID: 23608146
[TBL] [Abstract][Full Text] [Related]
20. B lymphocyte depletion therapy in children with refractory systemic lupus erythematosus.
Marks SD; Patey S; Brogan PA; Hasson N; Pilkington C; Woo P; Tullus K
Arthritis Rheum; 2005 Oct; 52(10):3168-74. PubMed ID: 16200620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
